Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / BBIO - Cullinan Oncology: Hub-And-Spoke Business Model For Drug Development


BBIO - Cullinan Oncology: Hub-And-Spoke Business Model For Drug Development

  • Cullinan is building a unique hub-and-spoke business model in drug development to build more efficient and scalable pipelines.
  • The company has already built out a pipeline of 7 assets and got the model off the ground to prove that they can structure their pipeline based on opportunistic deals.
  • Cullinan has a clinical catalyst for their lead asset coming up this year and 6 INDs over 2 years making the company worth monitoring to see if they can scale.

For further details see:

Cullinan Oncology: Hub-And-Spoke Business Model For Drug Development
Stock Information

Company Name: BridgeBio Pharma Inc.
Stock Symbol: BBIO
Market: NASDAQ
Website: bridgebio.com

Menu

BBIO BBIO Quote BBIO Short BBIO News BBIO Articles BBIO Message Board
Get BBIO Alerts

News, Short Squeeze, Breakout and More Instantly...